We further evaluated the in vivo anti-leukemic activity of mebendazole by engrafting the highly aggressive human THP-1 leukemia cells in immunodeficient NOD/SCID/IL2Rγ null (NSG) mice. The gene discussed is IL2RG; the disease is leukemia.